Anecortave
SENSORY ORGANS
Also known as: anecortave acetate, retaane
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Anecortave is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 2006. DrugCentral lists 1 molecular target, including SERPINE1. Recorded indications include Exudative age-related macular degeneration.
- Molecular targets: SERPINE1 (1 listed in DrugCentral).
- Indications: Exudative age-related macular degeneration.
- ATC code: S01LA02 (Antineovascularisation agents).
- Molecular formula: C23H30O5; molecular weight 386.49 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Exudative age-related macular degeneration
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Plasminogen activator inhibitor 1 | SERPINE1 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2006-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
S01LA02 | SENSORY ORGANS › OPHTHALMOLOGICALS › OCULAR VASCULAR DISORDER AGENTS › Antineovascularisation agents |
Chemical structure
| Molecular formula | C23H30O5 |
|---|---|
| Molecular weight | 386.49 g/mol |
| CAS number | — |
| InChIKey | YUWPMEXLKGOSBF-GACAOOTBSA-N |
| PubChem CID | 7074810 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Anecortave used for?
DrugCentral lists the following indications for Anecortave: Exudative age-related macular degeneration.
How does Anecortave work?
Its molecular targets in DrugCentral include SERPINE1.
When was Anecortave first approved?
Anecortave was first approved by the YEAR INTRODUCED in 2006.
What is the chemical formula of Anecortave?
Anecortave has the molecular formula C23H30O5 and a molecular weight of 386.49 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 217 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2106613 — compound record and bioactivity
- PubChem CID 7074810 — chemical identifiers
- DrugBank DB05288 — drug record
- FDA UNII R5Y8O51589 — substance identity
- UniProt P05121 (SERPINE1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.